Stay updated with breaking news from Nasdaq Siox. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) have earned a consensus rating of “Buy” from the seven research firms that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price […]
Sio Gene Therapies Inc. (NASDAQ:SIOX – Get Rating) was the target of a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 703,600 shares, an increase of 26.6% from the February 13th total of 555,800 shares. Based on an average daily volume of 582,300 shares, […]
Oral presentation to discuss new data updates from the high- and low-dose cohorts from the ongoing Phase 1/2 trial of AXO-AAV-GM1 for the treatment of GM1...
During the last session, Sio Gene Therapies Inc. (NASDAQ:SIOX)’s traded shares were 0.33 million, with the beta value of the company hitting 1.75. At the end of the trading day, the stock’s price was $2.49, reflecting an intraday gain of 1.63% or $0.04. The 52-week high for the SIOX share is $5.74, that puts it down -130.52 from that peak though still a striking 25.3% gain since the share price plummeted to a 52-week low of $1.86. The company’s market capitalization is $144.27M, and the average intraday trading volume over the past 10 days was 0.34 million shares, and the average trade ...
Sio Gene Therapies, Inc. (NASDAQ:SIOX)’s traded shares stood at 451,895 during the last session, with the company’s beta value hitting 1.7. At the close of trading, the stock’s price was $2.53, to imply an increase of 3.69% or $0.09 in intraday trading. The SIOX share’s 52-week high remains $5.74, putting it -126.88% down since that peak but still an impressive +26.48% since price per share fell to its 52-week low of $1.86. The company has a valuation of $146.2 Million, with an average of 834.2 Million shares in intraday trading volume over the past 10 days and average of 1.58 Million...